ArticleACR open rheumatology2023

Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set.

Sabina Ciciriello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.